Open access
Open access
Powered by Google Translator Translator

Radiation Oncology

Long-term results of RCT: Radiotherapy to the prostate for men with metastatic prostate cancer.

10 Jun, 2022 | 11:10h | UTC

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial – PLOS Medicine

 


ESTRO-ACROP guideline on surface guided radiation therapy.

7 Jun, 2022 | 10:53h | UTC

ESTRO-ACROP guideline on surface guided radiation therapy – Radiotherapy & Oncology

 

Commentary on Twitter

 


ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children.

7 Jun, 2022 | 10:52h | UTC

ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children – Radiotherapy & Oncology

 


M-A: Neoadjuvant short-course radiotherapy followed by consolidation chemotherapy before surgery for treating locally advanced rectal cancer.

3 Jun, 2022 | 10:46h | UTC

Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis – Current Oncology

 


Phase 2 RCT: Efficacy of epigallocatechin-3-gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy.

2 Jun, 2022 | 10:34h | UTC

Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial – JAMA Dermatology (free for a limited period)

Visual Abstract: Efficacy of Epigallocatechin-3-Gallate on Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy

 


M-A: Stereotactic radiosurgery vs. whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer.

30 May, 2022 | 10:41h | UTC

Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)

News Release: Meta-Analysis Shows Targeted Radiation Therapy May Be as Effective as Standard Care for Small Cell Lung Cancer Patients with Brain Metastases – St. Michael’s Hospital

 


RCT: Effect of supine vs. prone breast radiotherapy on acute toxic effects of the skin among women with large breast size.

27 May, 2022 | 11:51h | UTC

Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Editorial: Prone Whole-Breast Radiotherapy—Better Than Supine? (free for a limited period)

 

Commentary on Twitter

 


AUA/ASTRO Guideline: Clinically localized prostate cancer.

13 May, 2022 | 11:10h | UTC

Homepage: Clinically Localized Prostate Cancer: AUA/ASTRO Guideline – American Urological Association

Part I: Introduction, Risk Assessment, Staging and Risk-Based Management

Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

Part III: Principles of Radiation and Future Directions

Related:

Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy – European Urology

Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review – The Journal of Urology

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology

German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy – Urologia Internationalis

Therapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality

Radical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library

 


ASTRO Guideline: Radiation therapy for brain metastases.

12 May, 2022 | 10:11h | UTC

Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline – Practical Radiation Oncology

News Release: ASTRO issues clinical guideline on radiation therapy for brain metastases – American Society for Radiation Oncology

 

Commentary on Twitter

 


Review: Advances in radiation oncology for the treatment of cervical cancer.

6 May, 2022 | 10:20h | UTC

Advances in Radiation Oncology for the Treatment of Cervical Cancer – Current Oncology

 


RCT: Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy.

1 May, 2022 | 23:20h | UTC

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy – Journal of Clinical Oncology

 


Consensus Statement: Management of patients with advanced prostate cancer.

25 Apr, 2022 | 00:50h | UTC

Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 – European Urology

 

Commentary on Twitter

 


10-year results of a phase 3 RCT: High-dose radiotherapy and risk-adapted androgen deprivation in localized prostate cancer.

19 Apr, 2022 | 01:22h | UTC

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial – The Lancet Oncology (link to abstract – $ for full-text)

 


Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the Danish breast cancer group internal mammary node study.

11 Apr, 2022 | 00:41h | UTC

Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study – Journal of Clinical Oncology (link to abstract – $ for full-text)

 

Commentary from the author on Twitter (thread – click for more)

 


SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer.

25 Mar, 2022 | 08:21h | UTC

SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021) – Clinical and Translational Oncology

 


SEOM-TTCC clinical guideline in nasopharynx cancer.

25 Mar, 2022 | 08:20h | UTC

SEOM-TTCC clinical guideline in nasopharynx cancer (2021) – Clinical and Translational Oncology

 


RCT: Short-term radiotherapy plus chemotherapy vs. long-term chemoradiotherapy in locally advanced rectal cancer.

18 Mar, 2022 | 07:39h | UTC

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) – Journal of Clinical Oncology

 


Cohort Study: adjuvant vs. early salvage radiation therapy after radical prostatectomy for pN1 prostate cancer.

17 Mar, 2022 | 08:09h | UTC

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death – Journal of Clinical Oncology

Commentary: Adjuvant compared to early salvage therapy post prostatectomy in men with PN1 prostate cancer and decreased risk of mortality – Brigham and Women’s Hospital

 


RCT: In patients with low-risk thyroid cancer, thyroidectomy without ablation radioiodine was noninferior to thyroidectomy with ablation radioiodine at 3 years.

10 Mar, 2022 | 10:59h | UTC

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: New research casts doubt on a cornerstone of thyroid cancer treatment – STAT

 

Commentary on Twitter

 


GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer.

10 Mar, 2022 | 10:35h | UTC

GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer – Clinical and Translational Radiation Oncology

 


Review: Interaction between modern radiotherapy and immunotherapy for metastatic prostate cancer.

10 Mar, 2022 | 10:02h | UTC

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer – Frontiers in Oncology

 


RCT: Elective upper-neck vs. whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma.

9 Mar, 2022 | 08:17h | UTC

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries:

Elective Upper-Neck vs Whole-Neck Irradiation in Nasopharyngeal Carcinoma – The ASCO Post

Lower Neck-Sparing RT Succeeds in Nasopharyngeal Carcinoma— Phase III trial also shows that upper-neck irradiation leads to fewer late toxicities – MedPage Today (link to abstract – $ for full-text)

 


Perspective | Ultrahypofractionated radiotherapy for localized prostate cancer: how far can we go?

28 Jan, 2022 | 08:09h | UTC

Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go? – Clinical Oncology

 


ASCO-SNO Guideline: Therapy for diffuse astrocytic and oligodendroglial tumors in adults.

26 Jan, 2022 | 01:19h | UTC

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline – Journal of Clinical Oncology

 


Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.

21 Jan, 2022 | 09:36h | UTC

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline – Journal of Clinical Oncology

Related: EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumors.

 


Stay Updated in Your Specialty

No spam, just news.